A detailed history of Maple Capital Management, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Maple Capital Management, Inc. holds 4,528 shares of MDT stock, worth $397,196. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,528
Previous 4,450 1.75%
Holding current value
$397,196
Previous $387,000 8.01%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$78.71 - $87.02 $6,139 - $6,787
78 Added 1.75%
4,528 $356,000
Q1 2024

May 09, 2024

SELL
$82.84 - $88.09 $25,514 - $27,131
-308 Reduced 6.47%
4,450 $387,000
Q4 2023

Feb 07, 2024

BUY
$69.43 - $83.43 $26,244 - $31,536
378 Added 8.63%
4,758 $391,000
Q3 2023

Oct 10, 2023

BUY
$78.22 - $90.4 $76,029 - $87,868
972 Added 28.52%
4,380 $343,000
Q2 2023

Jul 14, 2023

SELL
$79.47 - $91.38 $8,423 - $9,686
-106 Reduced 3.02%
3,408 $300,000
Q1 2023

May 02, 2023

SELL
$76.72 - $87.58 $23,706 - $27,062
-309 Reduced 8.08%
3,514 $283,000
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $39,842 - $45,888
-523 Reduced 12.03%
3,823 $297,000
Q3 2022

Nov 15, 2022

SELL
$80.75 - $95.31 $7.56 Million - $8.92 Million
-93,562 Reduced 95.56%
4,346 $360,000
Q2 2022

Aug 02, 2022

SELL
$87.4 - $113.09 $602,448 - $779,529
-6,893 Reduced 6.58%
97,908 $8.79 Million
Q1 2022

May 17, 2022

SELL
$100.58 - $112.38 $368,424 - $411,647
-3,663 Reduced 3.38%
104,801 $11.6 Million
Q4 2021

Feb 15, 2022

BUY
$99.53 - $127.75 $497,749 - $638,877
5,001 Added 4.83%
108,464 $11.2 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $54,869 - $60,420
447 Added 0.43%
103,463 $13 Million
Q2 2021

Aug 16, 2021

BUY
$118.19 - $131.5 $770,126 - $856,854
6,516 Added 6.75%
103,016 $13.2 Million
Q1 2021

May 14, 2021

BUY
$111.18 - $119.74 $303,410 - $326,770
2,729 Added 2.91%
96,500 $11.4 Million
Q4 2020

Feb 12, 2021

SELL
$100.57 - $117.14 $11,364 - $13,236
-113 Reduced 0.12%
93,771 $11 Million
Q3 2020

Nov 16, 2020

BUY
$90.13 - $108.78 $131,229 - $158,383
1,456 Added 1.58%
93,884 $10.6 Million
Q2 2020

Aug 12, 2020

BUY
$84.11 - $103.33 $116,576 - $143,215
1,386 Added 1.52%
92,428 $8.48 Million
Q1 2020

May 14, 2020

BUY
$72.92 - $121.3 $45,647 - $75,933
626 Added 0.69%
91,042 $8.21 Million
Q4 2019

Feb 13, 2020

BUY
$104.49 - $114.54 $323,814 - $354,959
3,099 Added 3.55%
90,416 $10.3 Million
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $92,334 - $104,731
942 Added 1.09%
87,317 $9.48 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $39,634 - $46,807
-471 Reduced 0.54%
86,375 $8.41 Million
Q1 2019

May 15, 2019

BUY
$82.45 - $93.79 $158,139 - $179,889
1,918 Added 2.26%
86,846 $7.91 Million
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $115,486 - $133,913
1,346 Added 1.61%
84,928 $7.73 Million
Q3 2018

Nov 14, 2018

BUY
$85.91 - $99.17 $281,784 - $325,277
3,280 Added 4.08%
83,582 $0
Q2 2018

Aug 08, 2018

BUY
$77.48 - $87.83 $2.8 Million - $3.17 Million
36,084 Added 81.6%
80,302 $0
Q1 2018

May 11, 2018

BUY
$76.55 - $87.26 $3.13 Million - $3.57 Million
40,946 Added 1251.41%
44,218 $0
Q4 2017

Feb 15, 2018

BUY
$76.93 - $83.5 $769 - $835
10 Added 0.31%
3,272 $264,000
Q3 2017

Nov 03, 2017

BUY
$77.71 - $84.6 $253,490 - $275,965
3,262
3,262 $254,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Maple Capital Management, Inc. Portfolio

Follow Maple Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.